Drillon A, et al. Registrational results of LIBRETTO-001: a phase 1/2 trial of LOXO-292 in patients with RET fusion-positive lung cancer. Abstract PL02.08. WCLC 2019, 7-10 september, Barcelona, Spanje.
BRAF-MEK-remming bij nieuw gediagnosticeerd papillair craniofaryngeoom
nov 2023 | Neuro-oncologie